Chest
-
Bronchoscopy and Interventional Procedures PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To assess the diagnosis yield and complications of radial EBUS in peripheral pulmonary lesions. ⋯ The following authors have nothing to disclose: Helena Azcuna, Julio Pérez Izquierdo, Jose Javier Echeverria, Luis Tena, Mikel Egurrola, Sandra Dorado, Ane Uranga, Amaia Aramburu, Amaia Garcia Loizaga, Inmaculada Barredo, Cristobal Esteban, Alberto CapelasteguiNo Product/Research Disclosure Information.
-
SleepSESSION TYPE: Slide PresentationsPRESENTED ON: Monday, March 24, 2014 at 10:45 AM - 11:45 AMPURPOSE: Polysomnography (PSG) is a costly and time-consuming investigation for the evaluation of sleep apnea syndrome(SAS). Since it is not feasible to referred all individuals to PSG, it is useful to define predictors of OSA among these subjects. The aim is to identify specific patterns of developing apnea, by taking into consideration the multiple connections between risk factors in a relevant population of patients. Using a social network analysis pattern, we have developed incentives for predicting the apnea stage for any new patient by evaluating its network topological position and assigning a proposed ApnEa Risk score (AER)- a numerical predictor for the risk of severe apnea. ⋯ The following authors have nothing to disclose: Mihai Udrescu, Alexandru Topirceanu, Razvan Avram, Stefan MihaicutaNo Product/Research Disclosure Information.
-
Sleep Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMPURPOSE: Cardiologists and sleep/pulmonary physicians are increasingly co-managing patients in an environment of healthcare cost concerns and other increasing external pressures. The incidence of sleep apnea in patients with atrial fibrillation approaches 100%. Perhaps more concerning is the finding that 60% of patients with severe sleep apnea have significant ventricular arrhythmias. Patients initially diagnosed with arrhythmia due to subjective complaint of palpations may, in fact, have an underlying diagnosis of sleep apnea. Failure to recognize and treat sleep-related breathing disorders results in high costs, both financially and in terms of patients' morbidity and mortality. However, sleep apnea is underdiagnosed due to backlogs in sleep laboratories and limitations of at-home testing. ⋯ The following authors have nothing to disclose: Ian Grasso, Jacob Collen, Mark Haigney, William KellyNo Product/Research Disclosure Information.
-
Cancer Case Report Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Recurrent respiratory papillomatosis (RRP) is a common benign neoplasm of the larynx having the risk of malignancy (1). We present the treatment of a rare case as squamous cell lung cancer secondary to recurrent respiratory papillomatosis. ⋯ The following authors have nothing to disclose: Ebru Unsal, Filiz Çimen, Senem Yazici, Murat Yildiz, Atila Gökcek, Ebru Tatci, Funda DemiragNo Product/Research Disclosure Information.
-
Transplantation PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: We developed a protocol to procure human lungs from victims of cardiac arrest in an urban county in North Carolina by co-operation with Emergency Medical Services (EMS), our organ procurement organization (OPO), and our hospital, and evaluate them for transplant suitability with EVLP (XVIVO™). ⋯ Thomas Egan: Other: Received donations-in-kind (equipment and supplies) from XVIVO for this research, Shareholder: and Founder, X-In8 Biologicals Corporation, deveoping products to reduce ischemia-reperfusion injury for transplant. My spouse is paid hourly for bookkeeping of NIH-funded grants., Fiduciary position (of any organization, association, society, etc, other than ACCP: President and founder of Lung Banks of America, a 501(c)3 Corporation whose mission is to promote lung retrieval from non-heart-beating donors. I am not paid. My spouse will be paid to administer a subcontract on a NIH-funded subcontract as Sect-Treasurer., Grant monies (from sources other than industry): This work was supported by NIH grant 1RC2HL101641-01, which paid part of my salary John Blackwell: Other: My PI and my Department received donations-in-kind (equipment and supplies) from XVIVO for this project, Grant monies (from sources other than industry): This work was supported by NIH grant 1RC2HL101641-01, which paid part of my salary Lolita Forrest: Other: My PI and my Department received donations-in-kind (equipment and supplies) from XVIVO for this project, Grant monies (from sources other than industry): This work was supported by NIH grant 1RC2HL101641-01, which paid part of my salary William Simmons: Other: My PI and my Department received donations-in-kind (equipment and supplies) from XVIVO for this project, Grant monies (from sources other than industry): This work was supported by NIH grant 1RC2HL101641-01, which paid part of my salary Katherine Birchard: Grant monies (from sources other than industry): This work was supported by NIH grant 1RC2HL101641-01, which paid part of my salary William Funkhouser: Grant monies (from sources other than industry): This work was supported by NIH grant 1RC2HL101641-01, which paid part of my salary Boming Dong: Other: My PI and my Department received donations-in-kind (equipment and supplies) from XVIVO for this project, Grant monies (from sources other than industry): This work was supported by NIH grant 1RC2HL101641-01, which paid part of my salary Staci Beamer: Other: My PI and my Department received donations-in-kind (equipment and supplies) from XVIVO for this project Sheakar Reddy: Grant monies (from sources other than industry): This work was supported by NIH grant 1RC2HL101641-01, which paid part of my salary Nissa Casey: Grant monies (from sources other than industry): This work was supported by NIH grant 1RC2HL101641-01, which paid part of my salary The following authors have nothing to disclose: J Brent Meyers, Michael Bachman, Ginger Delario, Danielle NiedfeldtEx-vivo lung perfusion (EVLP) is not approved by the FDA in humans for transplant. EVLP of lungs retrieved after death is also not approved for use in humans. The presenter has an IDE from the FDA and UNC IRB approval to offer suitable lungs retrieved after death assessed by EVLP for transplant to consented patients.